Analia Bortolozzi
@aabortolozzi
Neuroscientist. Group Leader #CIBERSAM
#depression #Parkinson #stress #anhedonia #oligonucleotides #genetherapy #bortolozzilab
ID: 526145872
http://www.iibb.csic.es 16-03-2012 07:45:04
976 Tweet
746 Followers
816 Following
Impressive work of our talented María Sancho showing changes in cortical neuron activity in a mouse model of aSyn in serotonergic system #FEBS2024
New insights into the effects of serotonin on Parkinson's disease and depression through its role in the gastrointe… pubmed.ncbi.nlm.nih.gov/38992345/ a-Syn in gut-brain axis, already out!!!!! CIBERSAM CSIC en Catalunya CSIC Divulga IIBB - CSIC Lluis Miquel Unai Sarriés Serrano María Sancho
This nifty diagram shows all the #Parkinsons drug trials taking place. It's from the 2024 report, released this week in Journal of Parkinson's Disease (produced by Cure Parkinson's, michaeljfox.org & more), on the current state of #Parkinson's drug research 👉 Read more: buff.ly/3LH9YDE
📰 Revisan los mecanismos de actuación del #litio en el trastorno bipolar y otras enfermedades neurológicas 🔬 Analia Bortolozzi, Eduard Vieta, Giovanna Fico 📖Pharm Rev (ASPET) 🏛️IDIBAPS Hospital Clínic @Unibarcelona clinicbarcelona.org/noticias/revis…
Un nuevo artículo, ahora en elDiario.es que se ocupa de mostrar, negro sobre blanco, los obscenos beneficios de las editoriales de revistas científicas a partir del dinero que tenemos que pagar los investigadores para publicar nuestros resultados. Locura. eldiario.es/sociedad/mejor…
FDA encourages use of the alpha-synuclein (aSyn) seeding assay for selection #PD patients for clinical disease-modifying trials! This will be important for aSyn-targeted therapies, although we don't yet fully know the significance of an SAA negative result parkinsonsnewstoday.com/news/fda-lette…